Home
Cell Genesys

Cell Genesys Market Share Analysis for June 2026

see relevant content for cellgenesys.com

Science and Education > Biology

Domaincellgenesys.com

Year Founded--

Employees201 - 500

Annual Revenue--

Cell Genesys

Cell Genesys (including company regionals)

cellgenesys.com

See more website traffic and engagement information

Total visits to Cell Genesys's top domains

Understand Cell Genesys market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Cell Genesys's top domains

Analyze Cell Genesys engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Cell Genesys's top domains

See how Cell Genesys keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Cell Genesys top competitors by domain

Top similar sites in June 2026, ranked by their affinity

ebi.ac.ukCompany NameEmbl-ebiEmployees501 - 1000HQUnited Kingdom, HinxtonAnnual revenue$100M - $200MTotal visits1.2MScience and Education > Biology

Top technologies used by Cell Genesys

These are the website technologies, by industry, used by Cell Genesys top domains

Social (4)

Google+ Platform

Advertising (2)

Google Adsense

Mobile (2)

Meta Viewport

Widget (2)

Yoast SEO

More Technologies

2

See all

News & Signals from Cell Genesys

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsChris Adams left Cell Genesys, Inc. on Jan 1st '10.Cydan’s management team will also include Chris Adams as chief business officer, former chief business officer of FoldRx (acquired by Pfizer in 2010); James McArthur, chief scientific officer and former senior R&D executive at Synovex, Phylogix and Cell Genesys; and Deborah Geraghty, vice president of project and portfolio development, and a former senior portfolio management executive at Aileron Therapeutics and Infinity Pharmaceuticals.